Boston Scientific Corp. reported the latest setback in its transcatheter aortic valve replacement (TAVR) aspirations with the news that it is officially discontinuing worldwide sales of its Acurate ne ...

Medical-device maker Edwards Lifesciences shares ticked up after rival Boston Scientific said it would stop selling its rival heart-valve replacement systems. The systems, called transcatheter aortic ...

Boston Scientific will eliminate jobs after discontinuing global sales of its Acurate aortic valve replacement systems that ...

The 83-year-old actress - who played Professor Sprout in the 'Harry Potter' film franchise - underwent a procedure in 2023 to replace an aortic valve, which ensured she avoided more invasive open ...

Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to ...

Similar to testing a car, a team of researchers at UBC Okanagan has been test-driving a number of mechanical heart valves (MHV)—and the one designed in their own lab appears to outperform the others.

Shares of Boston Scientific Corporation (BSX) traded 1% lower on Wednesday afternoon after the company announced that it is ...

Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...

Boston Scientific has discontinued global sales of its Acurate neo2 and Acurate Prime transcatheter aortic valve replacement (TAVR) systems.

Boston Scientific said it still expects to achieve its second-quarter and full-year 2025 sales and adjusted per-share earnings guidance despite the anticipated financial impacts from the ...

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory ...